SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022281
Filing Date
2017-11-07
Accepted
2017-11-07 16:31:33
Documents
45
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 Q3'17 FORM 10-Q alny-10q_20170930.htm 10-Q 2072341
2 EX-10.1 alny-ex101_159.htm EX-10.1 61200
3 EX-31.1 alny-ex311_13.htm EX-31.1 18234
4 EX-31.2 alny-ex312_8.htm EX-31.2 18328
5 EX-32.1 alny-ex321_7.htm EX-32.1 7202
6 EX-32.2 alny-ex322_12.htm EX-32.2 7103
7 GRAPHIC g20171107184711163694.jpg GRAPHIC 29148
  Complete submission text file 0001564590-17-022281.txt   6573914

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT alny-20170930.xml EX-101.INS 1551604
9 XBRL TAXONOMY EXTENSION SCHEMA alny-20170930.xsd EX-101.SCH 31095
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alny-20170930_cal.xml EX-101.CAL 47004
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alny-20170930_def.xml EX-101.DEF 96258
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE alny-20170930_lab.xml EX-101.LAB 250600
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alny-20170930_pre.xml EX-101.PRE 188045
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36407 | Film No.: 171183779
SIC: 2834 Pharmaceutical Preparations